Organization
Eisai Co., Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Eisai Co., Ltd.
... devices, in addition to pharma products. Companies mentioned: Daiichi Sankyo, Valeant Pharmaceuticals, Eisai, Regeneron Pharmaceuticals, UCB, Les Laboratories Servier, Sun Pharmaceutical, Endo International, Mallinckrodt, Kyowa ...
... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') has announced that it has ...
... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') announced today that its research ...
... TOKYO - AbbVie GK (Headquarters: Tokyo, President: James Feliciano, 'AbbVie'), Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') and Eisai's subsidiary for gastrointestinal ...
... Eisai is set to close its site in Andover, Massachusetts, and move its ...
... Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced it will launch the Eisai Center for Genetics Guided ...
... using BACE drugs may only be effective before Alzheimer's has taken hold. RELATED:Eisai and Biogen's BACE drug lowers amyloid levels, but not Alzheimer's symptoms That ...
... While Eisai and Biogen's oral BACE inhibitor elenbecestat was able to demonstrate a reduction ...
... Eisai and Purdue Pharma have presented new clinical trial results of their dual ...
... Eisai Co., Ltd. (CEO: Haruo Naito, "Eisai") and Purdue Pharma L.P. (President and CEO: ...
Subscribe now for full coverage on Eisai Co., Ltd.
Start My Free Trial